Search

for
Search:

Glossary

Similar Terms

Non-Alcoholic Fatty Liver Disease

Learn

0 / 0 results

— no results

Research

5 / 192 results

Relation Between Non-Alcoholic Fatty Pancreas and Clinical and Biochemical Parameters in Women with Polycystic Ovary Syndrome: A Multi-Centric Study

research Relation Between Non-Alcoholic Fatty Pancreas and Clinical and Biochemical Parameters in Women with Polycystic Ovary Syndrome: A Multi-Centric Study

November 2022 in “International Journal of General Medicine”

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

research Metabolic Aspects of Polycystic Ovary Syndrome

August 2015 in “Postgraduate obstetrics & gynecology”

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Prevalence of Non-Alcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and Its Correlation with Metabolic Syndrome

research Prevalence of Non-Alcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and Its Correlation with Metabolic Syndrome

35 citations , May 2015 in “Arquivos De Gastroenterologia”

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

research Nonalcoholic Fatty Liver Disease in Young Adult Egyptian Women with Polycystic Ovary Syndrome

3 citations , January 2013 in “Egyptian Liver Journal”

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

research Predictivity of Fatty Liver Index for Non-Alcoholic Fatty Liver Disease in Lean Females with Polycystic Ovary Syndrome

2 citations , April 2022 in “African Health Sciences”

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

View more "nafpd" in research →

Community Join

5 / 24 results

community Nuclear Stack Ineffective: Oral DUT/FIN/MIN/RU - NAFLD?

in Finasteride/Dutasteride 1 upvotes 1 year ago

The user experienced severe hair shedding despite using oral finasteride, minoxidil, dutasteride, and RU58841, and was diagnosed with Non-Alcoholic Fatty Liver Disease (NAFLD). They are considering switching to topical treatments due to the ineffectiveness of their current regimen.

community Is this true? Is long term taking fin harmful to the liver?

in Chat 127 upvotes 2 years ago

The conversation discusses whether long-term use of finasteride (Fin) is harmful to the liver, with various opinions on side effects and comparisons to other substances. Specific treatments mentioned include finasteride, minoxidil (Min), and RU58841 (RU).

community A warning to those thinking about using Dutasteride

in Finasteride/Dutasteride 99 upvotes 5 years ago

The potential risks of long-term use of Dutasteride and how it may be linked to elevated liver enzymes, cholesterol levels, and decreased testosterone. Alternative treatments such as Finasteride and RU58841 were also discussed.

community Connection between finasteride and nafld?

in Research/Science 4 upvotes 1 year ago

Finasteride may affect liver function and cortisol levels, potentially linking it to non-alcoholic fatty liver disease (NAFLD). More research is needed to understand this connection fully.

community How much would a high dose dutasteride scalp dht inhibition be?

in Finasteride/Dutasteride 10 upvotes 1 year ago

The conversation discusses the potential for high doses of dutasteride to completely inhibit scalp DHT and speculates whether this could cure baldness when combined with a topical antiandrogen. Specific dosages mentioned are 0.5 mg reducing scalp DHT by 55% and 2.5 mg by about 79%.

View more "nafpd" in community →